Cysplatin and etoposide for metastatic testis cancer in a renal transplant recipientVOGELZANG, N. J.The Journal of urology. 1990, Vol 143, Num 6, pp 1235-1236, issn 0022-5347Article

Human renal cancer carcinogenesis: a review of recent advancesSTADLER, W; VOGELZANG, N. J.Annals of oncology. 1993, Vol 4, Num 6, pp 451-462, issn 0923-7534Article

Gemcitabine and other new chemotherapeutic agents for the treatment of metastatic bladder cancerVOGELZANG, N. J; STADLER, W. M.Urology (Ridgewood, NJ). 1999, Vol 53, Num 2, pp 243-250, issn 0090-4295Article

Subcutaneous interleukin-2 plus interferon alfa-2a in metastatic renal cancer : an outpatient multicenter trialVOGELZANG, N. J; LIPTON, A; FIGLIN, R. A et al.Journal of clinical oncology. 1993, Vol 11, Num 9, pp 1809-1816, issn 0732-183XArticle

Kidney cancerVOGELZANG, N. J; STADLER, W. M.Lancet (British edition). 1998, Vol 352, Num 9141, pp 1691-1696, issn 0140-6736Article

Chemotherapy in malignant pleural mesothelioma : A reviewTIONG ONG, S; VOGELZANG, N. J.Journal of clinical oncology. 1996, Vol 14, Num 3, pp 1007-1017, issn 0732-183XArticle

Diagnosis and treatment of leptomeningeal metastases in a patient with renal carcinoma responding to 5-fluorouracil and gemcitabineTIPPIN, D. B; REEVES, W; VOGELZANG, N. J et al.The Journal of urology. 1999, Vol 162, Num 1, pp 155-156, issn 0022-5347Article

Docetaxel (Taxotere) in hormone-refractory prostate cancer : A new addition to the physicians' toolbagVOGELZANG, N. J.Seminars in oncology. 1999, Vol 26, Num 5, pp 1-2, issn 0093-7754, SUP17Article

Spontaneous regression of histologically proved pulmonary metastases from renal cell carcinoma : a case with 5-year followupVOGELZANG, N. J; PRIEST, E. R; BORDEN, L et al.The Journal of urology. 1992, Vol 148, Num 4, pp 1247-1248, issn 0022-5347Article

Malignant mesothelioma : diagnostic and management strategies for 1992VOGELZANG, N. J.Seminars in oncology. 1992, Vol 19, Num 4, pp 64-71, issn 0093-7754, SUP11Conference Paper

Optimal drug therapy in the treatment of testicular cancerPRIEST, E. R; VOGELZANG, N. J.Drugs (Basel). 1991, Vol 42, Num 1, pp 52-64, issn 0012-6667Article

Phase I and pharmacological study of vinblastine by prolonged continuous infusionRATAIN, M. J; VOGELZANG, N. J.Cancer research (Baltimore). 1986, Vol 46, Num 9, pp 4827-4830, issn 0008-5472Article

Severe vascular toxicity associated with vinblastine, bleomycin, and cisplatin chemotherapySAMUELS, B. L; VOGELZANG, N. J; KENNEDY, B. J et al.Cancer chemotherapy and pharmacology. 1987, Vol 19, Num 3, pp 253-256, issn 0344-5704Article

High-dose continuous intravenous infusion of interleukin-2 therapy for metastatic renal cell carcinoma : the University of Chicago experienceSHULMAN, K. L; STADLER, W. M; VOGELZANG, N. J et al.Urology (Ridgewood, NJ). 1996, Vol 47, Num 2, pp 194-197, issn 0090-4295Article

Chemotherapy for non-small cell lung cancer : the continuing challengeVOKES, E. E; BITRAN, J. D; VOGELZANG, N. J et al.Chest. 1991, Vol 99, Num 6, pp 1326-1328, issn 0012-3692, 3 p.Article

A phase II study of spirogermanium in advanced human malignancyVOGELZANG, N. J; GESME, D. H; KENNEDY, B. J et al.American journal of clinical oncology. 1985, Vol 8, Num 4, pp 341-344, issn 0277-3732Article

Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycinVOGELZANG, N. J; TORKELSON, J. L; KENNEDY, B. J et al.Cancer. 1985, Vol 56, Num 12, pp 2765-2770, issn 0008-543XArticle

Phase I study of direct intralesional gene transfer of HLA-B7 into metastatic renal carcinoma lesionsRINI, B. I; SELK, L. M; VOGELZANG, N. J et al.Clinical cancer research. 1999, Vol 5, Num 10, pp 2766-2772, issn 1078-0432Article

Recent developments in endocrine treatment of prostate cancerVOGELZANG, N. J; KENNEALEY, G. T.Cancer. 1992, Vol 70, Num 4, pp 966-976, issn 0008-543X, SUPConference Paper

Interpatient and intrapatient variability in vinblastine pharmacokineticsRATAIN, M. J; VOGELZANG, N. J; SINKULE, J. A et al.Clinical pharmacology and therapeutics. 1987, Vol 41, Num 1, pp 61-67, issn 0009-9236Article

Successful treatment of mediastinal germ cell/endodermal sinus tumorsVOGELZANG, N. J; ANDERSON, R. W; KENNEDY, B. J et al.Chest. 1985, Vol 88, Num 1, pp 64-69, issn 0012-3692Article

Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8⁺ IFN-γ-producing T cellsHARLIN, H; ARTZ, A. S; MAHOWALD, M et al.Bone marrow transplantation (Basingstoke). 2004, Vol 33, Num 5, pp 491-497, issn 0268-3369, 7 p.Article

Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanomaAKLILU, M; STADLER, W. M; MARKIEWICZ, M et al.Annals of oncology. 2004, Vol 15, Num 7, pp 1109-1114, issn 0923-7534, 6 p.Article

Phase i and pharmacokinetic study of 24-hour infusion 5-fluorouracil and leucovorin in patients with organ dysfunctionFLEMING, G. F; SCHILSKY, R. L; SCHUMM, L. P et al.Annals of oncology. 2003, Vol 14, Num 7, pp 1142-1147, issn 0923-7534, 6 p.Article

Granulocyte-macrophage-colony stimulating factor in metastatic renal cell carcinoma: A phase II trialRINI, B. I; STADLER, W. M; SPIELBERGER, R. T et al.Cancer. 1998, Vol 82, Num 7, pp 1352-1358, issn 0008-543XArticle